SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $131,000 | -38.8% | 14,880 | -63.8% | 0.02% | -41.4% |
| Q1 2017 | $214,000 | +24.4% | 41,095 | -27.3% | 0.03% | +16.0% |
| Q4 2016 | $172,000 | -53.5% | 56,490 | -29.4% | 0.02% | -54.5% |
| Q3 2016 | $370,000 | +3.9% | 80,020 | +30.0% | 0.06% | -5.2% |
| Q2 2016 | $356,000 | -5.3% | 61,570 | -0.8% | 0.06% | -10.8% |
| Q1 2016 | $376,000 | -33.9% | 62,070 | -0.5% | 0.06% | -36.9% |
| Q4 2015 | $569,000 | +15.9% | 62,370 | -28.4% | 0.10% | +4.0% |
| Q3 2015 | $491,000 | -42.4% | 87,080 | +13.2% | 0.10% | -36.9% |
| Q2 2015 | $853,000 | -26.5% | 76,895 | +3.9% | 0.16% | -20.3% |
| Q1 2015 | $1,161,000 | +106.6% | 74,015 | +100.1% | 0.20% | +129.1% |
| Q4 2014 | $562,000 | +43.0% | 36,980 | +1.6% | 0.09% | +41.0% |
| Q3 2014 | $393,000 | – | 36,410 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |